Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks.

Moussa, Hind N; Hosseini Nasab, Susan; Haidar, Ziad A; Blackwell, Sean C; Sibai, Baha M

Moussa, Hind N; Hosseini Nasab, Susan; Haidar, Ziad A; Blackwell, Sean C; Sibai, Baha M.

Afiliação

Moussa HN; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Hosseini Nasab S; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Haidar ZA; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Blackwell SC; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Sibai BM; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Future Sci OA ; 2(2): FSO116, 2016 Jun.

Article em En | MEDLINE | ID: mdl-28031963

Palavras-chave

adverse pregnancy outcomes; folic acid; pre-conception supplement

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Future Sci OA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google